Millrace Asset Group’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-548,470
Closed -$987K 92
2024
Q2
$987K Sell
548,470
-208,334
-28% -$601K 0.96% 49
2024
Q1
$3.6M Buy
756,804
+31,435
+4% +$110K 3.62% 2
2023
Q4
$2.1M Buy
725,369
+487,591
+205% +$769K 2.08% 9
2023
Q3
$321K Sell
237,778
-153,345
-39% -$269K 0.4% 55
2023
Q2
$841K Sell
391,123
-244,084
-38% -$592K 0.88% 45
2023
Q1
$1.85M Buy
635,207
+37,223
+6% +$188K 2.16% 17
2022
Q4
$4.11M Sell
597,984
-47,417
-7% -$224K 4.66% 3
2022
Q3
$2.05M Buy
645,401
+15,670
+2% +$56.9K 2.59% 13
2022
Q2
$2.02M Buy
629,731
+139,395
+28% +$405K 1.89% 25
2022
Q1
$1.49M Buy
490,336
+378,588
+339% +$1.28M 1.08% 48
2021
Q4
$498K Buy
111,748
+133
+0.1% +$651 0.29% 76
2021
Q3
$732K Sell
111,615
-80,786
-42% -$775K 0.46% 67
2021
Q2
$3.08M Buy
192,401
+51,228
+36% +$708K 1.61% 20
2021
Q1
$1.75M Sell
141,173
-108,848
-44% -$1.67M 0.94% 55
2020
Q4
$2.78M Sell
250,021
-271,314
-52% -$2.04M 1.93% 10
2020
Q3
$2.53M Buy
521,335
+225,923
+76% +$857K 2.05% 12
2020
Q2
$570K Buy
+295,412
New +$606K 0.58% 64
2019
Q2
Sell
-125,000
Closed -$1.91M 74
2019
Q1
$1.91M Buy
+125,000
New +$2.07M 1.61% 31

Other funds holding STIM

Millrace Asset Group's STIM Position: Q3 2024 in Review

Millrace Asset Group sold out of Neuronetics (STIM) in Q3 2024, closing a stake of 548,470 shares — an estimated $987K sold.

Millrace Asset Group first reported a position in STIM in Q1 2019 and held it in 18 quarters. The position peaked at $4.11M in Q4 2022. 48 funds tracked by Wall St. Rank hold STIM as of Q3 2024.

  • Millrace Asset Group reported no remaining Neuronetics position as of Q3 2024 after selling out during the quarter.
  • Millrace Asset Group sold 548,470 Neuronetics shares in Q3 2024, an estimated $987K.
  • Millrace Asset Group first reported a position in Neuronetics in Q1 2019 and held it in 18 quarters.
  • Millrace Asset Group's Neuronetics position peaked at $4.11M in Q4 2022.
  • 48 funds tracked by Wall St. Rank held Neuronetics as of Q3 2024.

Based on Millrace Asset Group's 13F filing for Q3 2024, filed 13 Nov 2024.